ROISERV (02146) released its annual performance report, showing a net profit attributable to shareholders of 113 million yuan, a decrease of 1.06% year-on-year.

16:48 31/03/2026

Rongwanjia (02146) released its annual performance for the year ending December 31, 2025. The group achieved a revenue of 1.913 billion yuan, a decrease of 2.25% compared to the previous year; the net profit attributable to the owners of the parent company was 113 million yuan, a decrease of 1.06% compared to the previous year; and the basic earnings per share was 0.3 yuan.

ROISERV (02146) announced its annual performance ending on December 31, 2025. The group achieved a revenue of 1.913 billion yuan, a decrease of 2.25% year-on-year; the net profit attributable to the owners of the parent company was 0.113 billion yuan, a decrease of 1.06% year-on-year; and the basic earnings per share were 0.3 yuan. Community service revenue increased by approximately 0.3% from approximately 1.438 billion yuan in the fiscal year ending on December 31, 2024 to approximately 1.443 billion yuan in the fiscal year ending on December 31, 2025. This was mainly due to the active expansion of property management projects from Risesun Real Estate Development and its subsidiaries (excluding the group) (Risesun Group) and other third parties, leading to an increase in managed area.

MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.

Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.

CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.

MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.

Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.

CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.